Notwithstanding the heavy healthcare burden of cancer, research efforts in the field of oncology remain limited in the Arab world. Collectively, all 22 Arab countries contributed to a mere 1.52% of the world’s literature on cancer during the studied period. The overall trend revealed steady growth in the number of papers from the Arab world over the last 15 years. Egypt ranked first in terms of publications per average GDP, whereas Qatar ranked first concerning publications per average population. Comoros was revealed to have no cancer-related publications. The most reliable metric to assess and compare the research activity on cancer in Arab world countries was found to be the average population size which exhibited a strong correlation with the number of publications, whereas the correlation was weaker with GDP. This finding was echoed by another study on psoriasis research in the Arab world; [5] nevertheless, GDP was found to be the most accurate measure to assess stroke publications. [11]
Several socioeconomic factors may play a role in hindering cancer publications and research activity in the Arab world. First of all, Arab funding of research is still relatively modest. In 2013, the gross expenditure on research and development (GERD) by the entire Arab world constituted only 1.0% of total global expenditures on research. [12] Indeed, Arab states with the least publications in cancer research were mostly low-income countries such as Comoros, Djibouti, Mauritania, and Somalia. These countries suffer from poor health services, widespread poverty, and a lack of education. [13] On the other hand, Gulf countries such as the United Arab Emirates (UAE), Saudi Arabia, and Qatar have been increasingly pouring oil revenues into technology and science research, [14–16] which was markedly illustrated on February 9th, 2021, when the United Arab Emirates became the first Arab country and the fifth country worldwide to send a probe to Mars.[17] Deficient funding can impede the establishment of robust research infrastructures within Arab medical schools and medical centers. As a matter of fact, most Arab medical schools and hospitals remain patient-centered and clinically-oriented, as only recently has a research culture been prioritized. [15, 18]
Furthermore, wars, internal turmoil, and ongoing conflicts may further jeopardize research activity in the Arab world by channeling funds usually allocated for biomedical research activity towards military action and into fulfilling basic needs. War-torn countries also suffer from brain drain and insecure environments that can hamper research activity. [19, 20] This would thereby explain why Iraq, Libya, Palestine, Somalia, Sudan, Syria, and Yemen have fared relatively poorly in terms of research outcomes in the studied period.
In this study, Egypt had the highest productivity in publishing cancer-related research among Arab states. Major reasons include that the country boasts the biggest population among the studied countries [4], and one which suffers from alarmingly increasing rates of cancer [7, 21]. The most common diagnoses among the Egyptian population include liver cancer in males (33.6%) and breast cancer in females (32.0%). [22]
Concerning all the Arab world, breast, colorectal, and liver cancers garnered the most cancer-related publications. This finding is hardly surprising. Breast cancer is the most prevalent cancer in Arab countries, and its incidence keeps on increasing; [23, 24] liver cancer is a critical problem in males in Egypt and Saudi Arabia, the two leading countries in total cancer-related publications; [7] and some of the highest rates of colorectal cancer can be found among Gulf countries. [25]
Cancer is one of the leading causes of death in the Arab world, and its incidence remains on the rise in this region. [26, 27] To the best of the authors’ knowledge, this is the first study assessing the Arab world’s contribution to the field of oncology and the distribution of publications regarding each type of cancer. Despite its strengths, this bibliometric analysis should also be viewed in light of some limitations. Only one database (PubMed) was used to obtain the publications. Besides, only publications written in English were gathered in this study, therefore omitting papers released in Arabic or other languages. On this basis, the credibility of our results may be affected as the number of publications might be underestimated.